Our structure
Executive Board
Florence Baron-Papillon
President (Sanofi)
Juan Carlos Jaramillo
Vice-President & Treasurer (Valneva)
Andreas Potthoff
(Abbott)
Lorenzo Wittum
(AstraZeneca)
Basil Babychan
(Bilthoven Biologicals)
John-Kenneth Billingsley
(CSL Seqirus)
Guillermo De Juan Echávarri
(GSK)
Jörg Jenewein
(Moderna)
Nicoletta Luppi
(MSD)
Tobias Cousens
(Pfizer)
Walid Kandeil
(Takeda)
Executive Office
Sibila Quilici
Executive Director
Laurent Louette
Director Public Affairs & Country Liaison
Anna Czwarno
Director, Regulatory, Manufacturing & Supply
Charlotte Vernhes
Director, Scientific and Medical Affairs
Anna Vicere
Director, Public Affairs & Access Policy
Ingrid Weindorfer
Project Manager
Kateryna Khmilevska
Junior Science and Regulatory Manager
Polina Zoteva
Communications Lead
Eva Antunano
Assistant Manager
Working Group Chairs
Public Affairs
Nilsy Desaint
MSD
Regulatory Affairs
Andrew Deavin
GSK
RESEARCH, INNOVATION & MEDICAL
Lucie Rochard (interim)
Sanofi
Market Access
Kathleen Grieve
MSD
Manufacturing & Supply
Niko Salo
Pfizer
NATIONAL VACCINE INDUSTRY GROUP’S TASK FORCE
Gisela Payeras Bailly
GSK